Additional Studies Needed for Immunotherapy Combinations in Clear Cell Ovarian Carcinoma Cancer Network, 03 Oct 2022 Despite inconclusive efficacy results regarding the use of pembrolizumab plus epacadostat in patients with recurrent clear cell…